| Typicality: | 0.541 |
| Saliency: | 0.377 |
| for approval | 12 | purpose |
| to the european medicines agency | 7 | transitive-object |
| in russia | 7 | location |
| drug → be submitted to → the fda | 22 |
| drug → be submitted for → approval | 20 |
| drug → be submitted for → fda approval | 5 |
| drug → be filed for → approval | 4 |
| negative | neutral | positive |
| 0.086 | 0.702 | 0.212 |
| Raw frequency | 51 |
| Normalized frequency | 0.377 |
| Modifier score | 0.900 |
| Perplexity | 46.031 |